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Postpartum hemorrhage is one of the major causes of
maternal death, and can be separated into early and
delayed postpartum hemorrhage by the time of onset.
Early postpartum hemorrhage (< 24 hours) is often the
result of uterine atony or occult genital tract lacerations.
Delayed postpartum hemorrhage (> 24 hours through 6
weeks postpartum) is more commonly associated with
retained placental tissue, placental site subinvolution or
infection [1].
Thrombotic thrombocytopenic purpura (TTP) and
hemolytic uremic syndrome (HUS) are rare disorders that
share many clinical features. They are usually combined as
TTP-HUS. Organ ischemia resulting from thrombotic
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microangiopathy is believed to be the pathogenesis of
TTP-HUS. The incidence of TTP-HUS is recorded as 3.7 per
million adults per year in the USA. Females are more often
affected than males in a ratio of about 10:1 [2]. Pregnancy is
well known as a risk factor of TTP-HUS [3]. A review of the
literature reveals that women with TTP-HUS associated
with pregnancy become symptomatic relatively late in
pregnancy and in the immediate postpartum period.
Delayed postpartum hemorrhage is a rare clinical
presentation of TTP-HUS [4,5]. We report a case of TTP-
HUS with recurrent delayed postpartum hemorrhage and
dismal outcome.
CASE PRESENTATION
An 18-year-old woman, gravida 2, para 1, had an
uncomplicated cesarean section at 38 weeks’ gestation, at a
local clinic under the indication of a previous cesarean
section. The immediate postpartum course was uneventful.
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Her prenatal and medical histories were unremarkable.
Her blood pressure was within normal limits during
prenatal care and postpartum. Ten days after surgery, the
first episode of delayed postpartum hemorrhage occurred.
Laboratory analysis (only complete blood count) revealed
a hemoglobin count of 10.4g/dL, hematocrit of 29.7%,
platelet count of 368,000/mm3, and leukocyte count of
10,700/mm3. Two units of packed red blood cells (RBCs)
were transfused and the hemorrhage subsided. The second
and third episodes of postpartum hemorrhage were on the
26th and 37th days postpartum. The complete blood count
for the third episode showed decreased levels of
hemoglobin (8.0 g/dL) and hematocrit (23.4%). Medical
treatments, including oxytocin and ergonovine maleate,
and blood transfusion were administered. Fractional
dilatation and curettage was also performed under the
impression of retained placenta, but the pathology report
revealed a picture of decidual tissue only.
The fourth episode of postpartum hemorrhage
happened on the 42nd day postpartum. Laboratory analysis
revealed hemoglobin 7.2 g/dL, hematocrit 20.8%, platelet
count 142,000/mm3, and leukocyte count 6,500/mm3. No
fever, diarrhea, nausea, vomiting, or right upper quadrant
or epigastric pain were reported. She was referred to our
hospital because of recurrent postpartum hemorrhage
with unknown cause and low platelet count. At our
hospital, icteric sclera was the first noted sign. Vital signs
included a temperature of 37.5 $C, pulse of 82 beats per
minute, respiratory rate of 20/minute, and blood pressure
of 130/78 mmHg. Vaginal bleeding was not vigorous and
subsided with oxytocin treatment. A few hours after
admission, she developed a fever of more than 38 $C with
rapidly progressive jaundice. Oligouria and a small amount
of tea-colored urine were also noted. Laboratory studies
showed a normal leukocyte count (5,450/mm3), hemolytic
anemia (hemoglobin 7.5 g/dL, hematocrit 21.3%, and
positive fragmentation of RBCs), low platelet count
(85,000/mm3), elevated lactate dehydrogenase (2,987 u/L),
elevated aspartate transaminase (198 IU/L), and acute
renal failure (blood urea nitrogen 53 mg/dL, creatinine
4.3 mg/dL). Direct and indirect Coombs’ test were both
negative. Coagulation studies (prothrombin time and
partial thromboplastin time) were within normal ranges.
No mental status change was noted. Because her clinical
symptoms and laboratory studies suggested postpartum
TTP-HUS, she was transferred to the hematologic
department on the day after admission. Initial plasma
transfusion and steroid administration were followed by
emergency plasma exchange and hemodialysis on the
third day of admission. Further laboratory analyses
revealed poor response to treatment (hemoglobin 7.5 to
3.5 g/dL, platelet count 85,000 to 104,000/mm3). Serum
creatinine concentration was persistently elevated (4.3 to
8.3 on the third day of admission) despite continued
hemodialysis. Unfortunately, she died on the fourth day
of admission due to severe pulmonary edema and multiple
organ failure.
DISCUSSION
TTP and HUS are entities on a spectrum of thrombotic
microangiopathies. The classical features of TTP-HUS are
microangiopathic hemolytic anemia, thrombocytopenia,
renal failure, fever, and neurologic symptoms. Only 40%
of patients will have all the classical pentad of clinical
features [6]. Anuria indicates a poor prognosis. In a case
series of TTP-HUS associated with pregnancy, neurologic
symptoms (seizure, headache), gastrointestinal symptoms
(nausea, vomiting and abdominal pain), and decreased
amounts of urine are the usual initial presentations of
TTP-HUS [4,5,7]. Many other diseases, including
preeclampsia, eclampsia, and the HELLP syndrome
(hemolysis, elevated liver enzymes, low platelet level),
share the clinical symptoms and signs of TTP-HUS and it
is difficult to distinguish between them. Kahra et al reported
a case with probable coexistence of HELLP syndrome and
HUS that was confirmed by renal biopsy [8]. According to
our patient’s medical record, major causes of delayed
postpartum hemorrhage, including retained placental
tissue and infection, can be excluded. In this case, recurrent
delayed postpartum hemorrhage was the initial
presentation, and limited laboratory studies provided the
clinicians with little information about her first three
episodes of postpartum hemorrhage. When she was
transferred to our university hospital, she developed
an acute  i l lness ,  including hemolyt ic  anemia,
thrombocytopenia, acute renal failure, and fever, which
matched the features of TTP-HUS. We excluded septic or
hemorrhagic shock and disseminated intravascular
coagulopathy according to the initial stable vital signs and
laboratory studies. HELLP syndrome typically develops
in the third trimester with only a few cases developing in
the postpartum period, and the manifestations resolve
within the first 2 weeks postpartum. Besides, renal failure
is relatively unusual in HELLP syndrome. According to
her unremarkable prenatal and medical histories, HELLP
syndrome was considered very unlikely.
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In case series of TTP-HUS associated with pregnancy,
delayed postpartum hemorrhage is a rare clinical symptom
[4,5,7]. Review of the literature from a Medline search,
1966–2005, using the key words “pregnancy, postpartum
hemorrhage, thrombotic thrombocytopenic purpura, and
hemolytic uremic syndrome,” revealed only two previous
articles [9,10]. Rosen et al reported a 25-year-old patient who
developed postpartum TTP-HUS following an exploratory
laparotomy for hemoperitoneum resulting from a left uterine
artery laceration [9]. Wu et al reported a 32-year-old patient
who developed postpartum HUS following abruptio
placenta [10]. TTP-HUS developed in the immediate
postpartum period in both cases and both had a complicated
pregnancy or obstetric procedure. In our case, it was reported
that TTP-HUS developed on the 42nd postpartum day with
the initial symptom of postpartum hemorrhage. Vaginal
bleeding may lead the clinician to wrongly interpret
laboratory studies (low hematocrit and hemoglobin, and
decreased amount of urine) and miss the possibility of
hemolysis. Wu et al emphasize the importance of observation
of peripheral blood smears in patients with abruptio placenta
who develop thrombocytopenia after delivery [10]. In this
case, TTP-HUS could have been diagnosed earlier if
peripheral blood smears had been performed for the first
three episodes of postpartum hemorrhage.
The definite etiology of TTP-HUS is unknown. Many
factors have been implicated, including infection, cancer,
pregnancy, a variety of drugs (e.g. anticancer drugs), and
autoimmune diseases. Pregnancy may be a risk factor for TTP-
HUS because of the association of pregnancy with increasing
concentrations of procoagulant factors, decreasing fibrinolytic
activity, loss of endothelial cell thrombomodulin, and
decreasing activity of von Willebrand factor cleaving
metalloproteinase [11]. Early diagnosis and immediate
adequate treatment, including plasma exchange, plasma
infusion, and corticosteroid therapy, are very important factors
associated with a favorable outcome of TTP-HUS. Without
treatment, the mortality rate of TTP-HUS is more than 95%
[12]. Plasma exchange has been reported to produce a response
rate of about 77% and a 30-day mortality rate of 10% [13].
This case gave us an unusual experience, showing that
we should consider TTP-HUS in the differential diagnosis
when delayed postpartum hemorrhage is combined with a
disproportional decrease in hemoglobin and urine amount
and thrombocytopenia.
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